Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;27(3):109282.
doi: 10.1016/j.isci.2024.109282. eCollection 2024 Mar 15.

Global burden of head and neck cancers from 1990 to 2019

Affiliations

Global burden of head and neck cancers from 1990 to 2019

Tianjiao Zhou et al. iScience. .

Abstract

Head and neck cancer (HNC) exerts a significant healthcare burden worldwide. Insufficient data impedes a comprehensive understanding of its global impact. Through analysis of the 2019 Global Burden of Disease (GBD) database, our secondary investigation unveiled a surging global incidence of HNC, yet a decline in associated mortality and disability-adjusted life years (DALYs) owing to enhanced prognosis. Particularly noteworthy is the higher incidence of escalation among females compared to males. Effective resource allocation, meticulous control of risk factors, and tailored interventions are imperative to curtail mortality rates among young individuals afflicted with HNC in underprivileged regions, as well as in elderly individuals grappling with thyroid cancer.

Keywords: Biological sciences; Cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Age-standardized disease burden and estimated annual percentage change of head and neck cancer across 204 countries and territories from 1990 to 2019 (A) ASIR of head and neck cancer across 204 countries and territories from 1990 to 2019. (B) EAPC in ASIR of head and neck cancer across 204 countries and territories from 1990 to 2019. (C) ASDR of head and neck cancer across 204 countries and territories from 1990 to 2019. (D) EAPC in ASDR of head and neck cancer across 204 countries and territories from 1990 to 2019. (E) Age-standardized DALYs of head and neck cancer across 204 countries and territories from 1990 to 2019. (F) EAPC in Age-standardized DALYs of head and neck cancer across 204 countries and territories from 1990 to 2019. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years; EAPC, estimated annual percentage change.
Figure 2
Figure 2
Trends in the disease burden of head and neck cancer from 1990 to 2019 by different SDI level regions (A) Trends in incidence of head and neck cancer from 1990 to 2019 by different SDI level regions. (B) Trends in deaths of head and neck cancer from 1990 to 2019 by different SDI level regions. (C) Trends in DALYs of head and neck cancer from 1990 to 2019 by different SDI level regions. (D) Trends in ASIR of head and neck cancer from 1990 to 2019 by different SDI level regions. (E) Trends in ASDR of head and neck cancer from 1990 to 2019 by different SDI level regions. (F) Trends in age-standardized DALYs of head and neck cancer from 1990 to 2019 by different SDI level regions. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years; SDI, socio-demographic index.
Figure 3
Figure 3
Trends in disease burden of head and neck cancer across Global and 21 GBD regions by SDI from 1990 to 2019 (A) Trends in ASIR of head and neck cancer across Global and 21 GBD regions by SDI from 1990 to 2019. (B) Trends in ASDR of head and neck cancer across Global and 21 GBD regions by SDI from 1990 to 2019. (C) Trends in age-standardized DALYs of head and neck cancer across Global and 21 GBD regions by SDI from 1990 to 2019. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years; SDI, socio-demographic index.
Figure 4
Figure 4
Trends in disease burden of head and neck cancer across SDI level regions by gender from 1990 to 2019 (A) The trends in incidence of head and neck cancer across SDI level regions by gender from 1990 to 2019. (B) The trends in deaths of head and neck cancer across SDI level regions by gender from 1990 to 2019. (C) The trends in DALYs of head and neck cancer across SDI level regions by gender from 1990 to 2019. (D) The trends in ASIR of head and neck cancer across SDI level regions by gender from 1990 to 2019. (E) The trends in ASDR of head and neck cancer across SDI level regions by gender from 1990 to 2019. (F) The trends in age-standardized DALYs of head and neck cancer across SDI level regions by gender from 1990 to 2019. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years; SDI, socio-demographic index.
Figure 5
Figure 5
Trends in disease burden of head and neck cancer across different age groups (5-year intervals) by gender in 2019 (A) Trends in incidence and ASIR of head and neck cancer across different age groups (5-year intervals) by gender in 2019. (B) Trends in deaths and ASDR of head and neck cancer across different age groups (5-year intervals) by gender in 2019. (C) Trends in DALYs and age-standardized DALYs of head and neck cancer across different age groups (5-year intervals) by gender in 2019. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years. Data are represented as mean ± SEM.
Figure 6
Figure 6
Trends in disease burden of head and neck cancer subtypes from 1990 to 2019 (A) Trends in incidence and ASIR of head and neck cancer across different age groups (5-year intervals) by gender in 2019. (B) Trends in deaths and ASDR of head and neck cancer across different age groups (5-year intervals) by gender in 2019. (C) Trends in DALYs and age-standardized DALYs of head and neck cancer across different age groups (5-year intervals) by gender in 2019. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; DALYs, disability-adjusted life years.

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Bhatia A., Burtness B. Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update. Drugs. 2023;83:217–248. doi: 10.1007/s40265-023-01835-2. - DOI - PubMed
    1. GBD 2019 Cancer Risk Factors Collaborators The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400:563–591. doi: 10.1016/S0140-6736(22)01438-6. - DOI - PMC - PubMed
    1. Chow L.Q.M. Head and Neck Cancer. N. Engl. J. Med. 2020;382:60–72. doi: 10.1056/NEJMra1715715. - DOI - PubMed
    1. Raudenská M., Balvan J., Masařík M. Cell death in head and neck cancer pathogenesis and treatment. Cell Death Dis. 2021;12:192. doi: 10.1038/s41419-021-03474-5. - DOI - PMC - PubMed

LinkOut - more resources